Cite
HARVARD Citation
Plessier, A. et al. (2022). Paroxysmal nocturnal hemoglobinuria and vascular liver disease: Eculizumab therapy decreases mortality and thrombotic complications. American journal of hematology. 97 (4), pp. 431-439. [Online].